CHRISTINA ROSS: Open Payments
NPI 1356756357 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 20 payments from 9 companies in 2025. Trend: 2023 $281 · 2024 $565 · 2025 $504
Food & beverage: $504
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $356 |
| Astellas Pharma US Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $4 |
Products named: FARXIGA, AIRSUPRA, BREZTRI, Veozah, TRINTELLIX, KEVEYIS, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across LA — which companies pay providers there.
